Literature DB >> 21445572

Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.

Sihua Peng1, Bingjian Lü, Wenjing Ruan, Yimin Zhu, Hongqiang Sheng, Maode Lai.   

Abstract

To address the association between variants and breast cancer, an increasing number of articles on genetic association studies, genome-wide association studies (GWASs), and related meta- and pooled analyses have been published. Such studies have prompted an updated assessment of the associations between gene variants and breast cancer risk. We searched PubMed, Medline, and Web of Science and retrieved a total of 87 meta- and pooled analyses, which addressed the associations between 145 gene variants and breast cancer. Analyses met the following criteria: (1) breast cancer was the outcome, (2) the articles were all published in English, and (3) in the recent published meta- and pooled analyses, the analyses with more subjects were selected. Among the 145 variants, 46 were significantly associated with breast cancer and the other 99 (in 62 genes) were not significantly associated with breast cancer. The summary ORs for the 46 significant associations (P < 0.05) were further assessed by the method of false-positive report probability (FPRP). Our results demonstrated that 10 associations were noteworthy: CASP8 (D302H), CHEK2 (*1100delC), CTLA4 (+49G>A), FGFR2 (rs2981582, rs1219648, and rs2420946), HRAS (rare alleles), IL1B (rs1143627), LSP1 (rs3817198), and MAP3K1 (rs889312). In addition, eight GWASs were identified, in which 25 loci were obtained (14 in nine genes, six near a gene or genes, and five intergenic loci). Of the 25 SNPs, 20 were noteworthy: C6orf97 (rs2046210 and rs3757318), FGFR2 (rs2981579, rs1219648, and rs2981582), LSP1 (rs909116), RNF146 (rs2180341), SLC4A7 (rs4973768), MRPS30 (rs7716600), TOX3 (rs3803662 and rs4784227), ZNF365 (rs10995190), rs889312, rs614367, rs13281615, rs13387042, rs11249433, rs1011970, rs614367, and rs1562430. In summary, in this review of genetic association studies, 31.7% of the gene-variant breast cancer associations were significant, and 21.7% of these significant associations were noteworthy. However, in GWASs, 80% of the significant associations were noteworthy.

Entities:  

Mesh:

Year:  2011        PMID: 21445572     DOI: 10.1007/s10549-011-1459-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  41 in total

Review 1.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

2.  The role of genome sequencing in personalized breast cancer prevention.

Authors:  Weiva Sieh; Joseph H Rothstein; Valerie McGuire; Alice S Whittemore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

Review 3.  Mitochondrial determinants of cancer health disparities.

Authors:  Aaheli Roy Choudhury; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-06       Impact factor: 15.707

4.  Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.

Authors:  Sarah J Nyante; Marilie D Gammon; Jay S Kaufman; Jeannette T Bensen; Dan Yu Lin; Jill S Barnholtz-Sloan; Yijuan Hu; Qianchuan He; Jingchun Luo; Robert C Millikan
Journal:  Cancer Causes Control       Date:  2014-11-25       Impact factor: 2.506

5.  Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database.

Authors:  Heidi A Hanson; Claire L Leiser; Michael J Madsen; John Gardner; Stacey Knight; Melissa Cessna; Carol Sweeney; Jennifer A Doherty; Ken R Smith; Philip S Bernard; Nicola J Camp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-25       Impact factor: 4.254

6.  Association of TGF-β1 -509C/T polymorphisms with breast cancer risk: evidence from an updated meta-analysis.

Authors:  Yadong Wang; Xinwei Chu; Xiaojing Meng; Fei Zou
Journal:  Tumour Biol       Date:  2013-08-28

Review 7.  The SLC4 family of bicarbonate (HCO₃⁻) transporters.

Authors:  Michael F Romero; An-Ping Chen; Mark D Parker; Walter F Boron
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

8.  A likelihood ratio test for genome-wide association under genetic heterogeneity.

Authors:  Meng Qian; Yongzhao Shao
Journal:  Ann Hum Genet       Date:  2013-01-31       Impact factor: 1.670

9.  The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.

Authors:  Soley Bayraktar; Patricia A Thompson; Suk-Young Yoo; Kim-anh Do; Aysegul A Sahin; Banu K Arun; Melissa L Bondy; Abenaa M Brewster
Journal:  Oncologist       Date:  2013-05-01

10.  Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.

Authors:  Young-Kyoung Lee; Jin J Lim; Un-Woo Jeoun; Seongki Min; Eun-Beom Lee; So Mee Kwon; Changhan Lee; Gyesoon Yoon
Journal:  J Biol Chem       Date:  2017-10-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.